Publicação: International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies
dc.contributor.author | Bolon, Brad | |
dc.contributor.author | Barale-Thomas, Erio | |
dc.contributor.author | Bradley, Alys | |
dc.contributor.author | Ettlin, Robert A. | |
dc.contributor.author | Franchi, Carla Adriene da Silva [UNESP] | |
dc.contributor.author | George, Catherine | |
dc.contributor.author | Giusti, Anna Maria | |
dc.contributor.author | Hall, Robert | |
dc.contributor.author | Jacobsen, Matthew | |
dc.contributor.author | Konishi, Yoichi | |
dc.contributor.author | Ledieu, David | |
dc.contributor.author | Morton, Daniel | |
dc.contributor.author | Park, Jae-Hak | |
dc.contributor.author | Scudamore, Cheryl L. | |
dc.contributor.author | Tsuda, Hiroyuki | |
dc.contributor.author | Vijayasarathi, S. K. | |
dc.contributor.author | Wijnands, Marcel V. W. | |
dc.contributor.institution | GEMpath Inc | |
dc.contributor.institution | Johnson & Johnson PRD | |
dc.contributor.institution | Precclin Serv Europe | |
dc.contributor.institution | Ettlin Consulting AG | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Ipsen Innovat | |
dc.contributor.institution | Accelera Srl | |
dc.contributor.institution | Covance Labs | |
dc.contributor.institution | AstraZeneca | |
dc.contributor.institution | Yamamoto Green Village II 303 | |
dc.contributor.institution | Novartis Inst BioMed Res | |
dc.contributor.institution | Pfizer Inc | |
dc.contributor.institution | Seoul Natl Univ | |
dc.contributor.institution | Royal Vet Coll | |
dc.contributor.institution | Nagoya City Univ | |
dc.contributor.institution | Advinus Therapeut Pvt Ltd | |
dc.contributor.institution | Merck Sharp & Dohme Ltd | |
dc.date.accessioned | 2014-05-20T13:37:28Z | |
dc.date.available | 2014-05-20T13:37:28Z | |
dc.date.issued | 2010-09-01 | |
dc.description.abstract | The International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type nonclinical toxicology studies. Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain 4 or more years of intensive pathology practice during a residency and/or on-the-job "apprenticeship," at least 2 years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A non-clinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one's understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies. (J Toxicol Pathol 2010; 23: 171-181) | en |
dc.description.affiliation | GEMpath Inc, Longmont, CO 80503 USA | |
dc.description.affiliation | Johnson & Johnson PRD, Pathol, B-2340 Beerse, Belgium | |
dc.description.affiliation | Precclin Serv Europe, Edinburgh EH33 2NE, Midlothian, Scotland | |
dc.description.affiliation | Ettlin Consulting AG, CH-4142 Munchenstein, Switzerland | |
dc.description.affiliation | UNESP, Fac Med, Dept Patol, BR-18618000 Botucatu, SP, Brazil | |
dc.description.affiliation | Ipsen Innovat, Toxicol, F-91940 Les Ulis, France | |
dc.description.affiliation | Accelera Srl, Pathol, I-20014 Milan, Italy | |
dc.description.affiliation | Covance Labs, Madison, WI 53704 USA | |
dc.description.affiliation | AstraZeneca, Safety Assessment, Macclesfield SK10 4TG, Cheshire, England | |
dc.description.affiliation | Yamamoto Green Village II 303, Kita Ku, Osaka 5918023, Japan | |
dc.description.affiliation | Novartis Inst BioMed Res, WKL 136 2 94, CH-4001 Basel, Switzerland | |
dc.description.affiliation | Pfizer Inc, Groton, CT 06340 USA | |
dc.description.affiliation | Seoul Natl Univ, Coll Vet Med, Lab Anim Med, Seoul, South Korea | |
dc.description.affiliation | Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield AL9 7TA, Herts, England | |
dc.description.affiliation | Nagoya City Univ, Nanotoxicol Project, Mizuho Ku, Nagoya, Aichi 4678603, Japan | |
dc.description.affiliation | Advinus Therapeut Pvt Ltd, Dept Safety Assessment, Bangalore 560058, Karnataka, India | |
dc.description.affiliation | Merck Sharp & Dohme Ltd, NL-5340 BH Oss, Netherlands | |
dc.description.affiliationUnesp | UNESP, Fac Med, Dept Patol, BR-18618000 Botucatu, SP, Brazil | |
dc.format.extent | 171-181 | |
dc.identifier | http://dx.doi.org/10.1293/tox.23.171 | |
dc.identifier.citation | Journal of Toxicologic Pathology. Tokyo: Japanese Soc Toxicologic Pathology, v. 23, n. 3, p. 171-181, 2010. | |
dc.identifier.doi | 10.1293/tox.23.171 | |
dc.identifier.issn | 0914-9198 | |
dc.identifier.uri | http://hdl.handle.net/11449/12965 | |
dc.identifier.wos | WOS:000282660200010 | |
dc.language.iso | eng | |
dc.publisher | Japanese Soc Toxicologic Pathology | |
dc.relation.ispartof | Journal of Toxicologic Pathology | |
dc.relation.ispartofjcr | 1.066 | |
dc.relation.ispartofsjr | 0,453 | |
dc.rights.accessRights | Acesso aberto | |
dc.source | Web of Science | |
dc.subject | toxicologic pathologists | en |
dc.subject | proposed curriculum | en |
dc.subject | training standards | en |
dc.subject | regulatory-type non-clinical safety studies | en |
dc.title | International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies | en |
dc.type | Artigo | |
dcterms.rightsHolder | Japanese Soc Toxicologic Pathology | |
dspace.entity.type | Publication | |
unesp.author.lattes | 9163387140787963[5] | |
unesp.author.orcid | 0000-0002-2830-2540[5] | |
unesp.campus | Universidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatu | pt |
unesp.department | Patologia - FMB | pt |
Arquivos
Licença do Pacote
1 - 2 de 2
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: